MIM SurePlan MRT

by MIM Software
VISIT OFFICIAL WEBSITE →
Disclaimer: This page is an independent third-party listing and is not affiliated with, sponsored by, or endorsed by MIM SurePlan MRT or MIM Software. All product names, logos, and brands are property of their respective owners.

OVERVIEW

Automated, vendor-neutral dosimetry software for molecular radiotherapy (MRT) and theranostics, featuring AI-driven segmentation and voxel-based dose calculation.

MIM SurePlan MRT is a comprehensive software solution developed by MIM Software (now a GE HealthCare Company) for Molecular Radiotherapy (MRT) dosimetry, designed to streamline and standardize the entire workflow from image acquisition to reporting. It is a vendor-neutral platform, meaning it supports quantitative SPECT reconstruction (via SPECTRA Quant™) and planar corrections on existing cameras from various vendors, helping to standardize measurements across a department.

Key Features and Capabilities

The software provides timesaving, patient-specific tools for organ and tumor segmentation, deformable registration, and voxel-based dosimetry. It performs absorbed dose calculation using the patient's own anatomy (voxel-based dosimetry), which is considered more precise than model-based methods.

  • AI-Driven Automation: Features "zero-click" AI-driven auto-segmentation (Contour ProtégéAI™) for normal structures (like liver and kidneys) and tumors, significantly reducing manual effort and inter-user variability.
  • Patient-Specific Dosimetry: Calculates absorbed dose using the Voxel S-Value (VSV) schema in MIRD Pamphlet No. 17, providing dose maps and Dose-Volume Histograms (DVH) for analysis.
  • Multi-Isotope Support: Supports FDA-cleared and CE-marked therapies for Lu-177 and I-131, as well as numerous other radionuclides (e.g., I-123, Cu-64, Y-90, Ac-225) for research and clinical use.
  • Dose Accumulation: Tracks and accumulates dose and volume changes across multiple therapy cycles.
  • Integrated Reporting: Offers customizable reporting solutions that incorporate images, statistics, and DVH curves for referring physicians and patients.
  • Dosimetry Techniques: Supports both Single-Time-Point and Multiple-Time-Point dosimetry for flexible workflow.

Target Users and Use Cases

MIM SurePlan MRT is primarily used by medical physicists, nuclear medicine physicians, and oncologists in hospitals and leading theranostics centers. Its main use cases include:

  1. Molecular Radiotherapy (MRT) Dosimetry: Providing accurate, personalized absorbed dose measurements for RPT treatments.
  2. Theranostics Treatment Planning: Aiding in the planning and monitoring of multi-tracer theranostics protocols.
  3. Clinical Workflow Standardization: Automating and standardizing complex dosimetry processes to maximize efficiency and clinical value.

RATING & STATS

Founded
2003

KEY FEATURES

  • Voxel-based Patient-Specific Dosimetry
  • AI-Driven Auto-Segmentation (Contour ProtégéAI™)
  • Vendor-Neutral Quantitative SPECT Reconstruction
  • Multi-Modality Rigid and Deformable Alignment
  • Integrated and Customizable Dosimetry Reporting
  • Dose Accumulation Across Therapy Cycles

PRICING

Model: enterprise
Contact vendor for a quote. Standard enterprise licensing model for hospitals and specialized centers.

TECHNICAL DETAILS

Deployment: cloud, on_premise, saas
Platforms: web, windows, mac, ios
📱 Mobile Apps

USE CASES

Molecular Radiotherapy (MRT) DosimetryTheranostics Treatment PlanningPersonalized Dosimetry for Lu-177 and I-131

INTEGRATIONS

Vendor-Neutral SPECT/PET CamerasMIM MaestroMIM EncoreMIM LesionID Pro

COMPLIANCE & SECURITY

Compliance:
FDA 510(k)CE MarkSOC 2 Type 2GDPR
Security Features:
  • 🔒Strong Encryption
  • 🔒Password Management Policy
  • 🔒Secure Code Review Process

SUPPORT & IMPLEMENTATION

Support: email, phone, 24/7 support
Target Company Size: medium, enterprise
TRAINING AVAILABLE

PROS & CONS

✓ Pros:
  • +High-precision, patient-specific voxel-based dosimetry.
  • +Vendor-neutrality allows use with existing SPECT/PET cameras.
  • +Significant time savings through AI-driven auto-segmentation and automation.
  • +Comprehensive workflow from reconstruction to integrated reporting.
✗ Cons:
  • -Pricing is not publicly disclosed (enterprise model).
  • -Highly specialized software may require a steep learning curve for new users.
  • -Limited public user reviews/ratings available.

TRY IT OUT

ABOUT MIM SOFTWARE

Other software by MIM Software:
MIM Encore (Nuclear Medicine & Molecular ImagingSPECT imaging software)
MIM Software (Nuclear Medicine & Molecular ImagingPET/CT analysis platforms)
MIM Theranostics Solutions (Nuclear Medicine & Molecular ImagingTheranostics platforms)
MIMcardiac (Nuclear Medicine & Molecular ImagingCardiac nuclear medicine)